[APLS] QoQ Quarter Result on 30-Sep-2018 [#Q3]

Stock
[APLS] Apellis Pharmaceuticals, Inc.
Announcement Date
13-Nov-2018
Financial Year
2018
Quarter
30-Sep-2018 [#Q3]
Profit Trend
QoQ- -7.91%
YoY- -210.83%
Quarter Report
APLS's Result
APLS's Financial Summary
View:
Show?
Quarter Result
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
Revenue 0 0 12 0 0 0 12 -
PBT -71,090 -50,574 -36,459 -35,972 -33,334 -21,736 -18,256 148.13%
Tax 388 340 2,383 -281 -33,669 267 -17,896 -
NP -71,090 -50,574 -36,459 -35,972 -33,334 -21,736 -18,256 148.13%
Tax Rate - - - - - - - -
Total Cost 71,090 50,574 36,471 35,972 33,334 21,736 18,267 148.03%
Ratio Analysis
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
NP Margin 0.00 0.00 -315,885.24 0.00 0.00 0.00 -158,169.26 -
Per Share
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
EPS -1.12 -0.87 -0.65 -0.64 -0.61 -0.43 -0.36 113.55%
EPS Diluted -1.12 -0.87 -0.63 -0.64 -0.61 -0.43 -0.36 113.55%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.